Tag: report

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

STEINHAUSEN, Switzerland, June 16, 2026 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced contract awards for two of its harsh environment semisubmersibles. In aggregate, the fixtures represent approximately $185 million in firm contract backlog.

Alongside, by TimelyCare, analyzes 1 million+ student interactions to reveal critical trends in belonging, motivation, and attendance

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company,  announced today that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, the Company’s notice of intention to make a normal course issuer bid (the “TSX NCIB”).

PLANO, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- The latest Chapwood Index findings show that Americans continue to experience cost-of-living increases that dramatically exceed the inflation rates reported by the Consumer Price Index (CPI), raising serious concerns about the use of CPI as the nation’s primary measure of inflation and purchasing power.